The promise and peril of genomic screening in the general population

Genetics in Medicine

Volumn 18, Issue 6, 2016, Pages 593-599

  Adams, Michael C ^a   Evans, James P ^a   Henderson, Gail E ^a   Berg, Jonathan S ^a  

^a UNIVERSITY OF NORTH CAROLINA SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; EXOME; HUMAN; MAJOR CLINICAL STUDY; POPULATION; PREDICTIVE VALUE; PREVALENCE; SCREENING; TASK PERFORMANCE; FALSE POSITIVE RESULT; GENETIC DISORDER; GENETIC SCREENING; GENETICS; GENOMICS; POPULATION GENETICS; PROCEDURES; WHOLE EXOME SEQUENCING;

FALSE POSITIVE REACTIONS; GENETIC DISEASES, INBORN; GENETIC TESTING; GENETICS, POPULATION; GENOMICS; HUMANS; WHOLE EXOME SEQUENCING;

EID: 84975076426     PISSN: 10983600     EISSN: 15300366     Source Type: Journal    
DOI: 10.1038/gim.2015.136     Document Type: Article

References (23)

1. Kemper AR, Green NS, Calonge N, et al. Decision-making process for conditions nominated to the recommended uniform screening panel: statement of the US Department of Health and Human Services Secretary's Advisory Committee on Heritable Disorders in Newborns and Children. Genet Med 2014; 16: 183-187
2. Evans JP, Berg JS, Olshan AF, Magnuson T, Rimer BK. We screen newborns, don't we: realizing the promise of public health genomics. Genet Med 2013; 15: 332-334
3. Geisinger. Genomic Sequencing Study Overview. http://www.geisinger.org/forresearchers/research-At-geisinger/genomic-study. Accessed 17 March 2015
4. Genomics England. http://www.genomicsengland.co.uk. Accessed 17 March 2015
5. King MC, Levy-Lahad E, Lahad A. Population-based screening for BRCA1 and BRCA2: 2014 Lasker Award. JAMA 2014; 312: 1091-1092
6. Xue Y, Chen Y, Ayub Q, et al.; 1000 Genomes Project Consortium. Deleteriousand disease-Allele prevalence in healthy individuals: insights from current predictions, mutation databases and population-scale resequencing. Am J Hum Genet 2012; 91: 1022-1032
7. Stenson PD, Mort M, Ball EV, Shaw K, Phillips A, Cooper DN. The Human Gene Mutation Database: building a comprehensive mutation repository for clinical and molecular genetics, diagnostic testing and personalized genomic medicine. Hum Genet 2014; 133: 1-9
8. Woo HI, Woo YM, Kim S, Lee ST, Ki CS, Kim JW. Challenges in assessing pathogenicity based on frequency of variants in mismatch repair genes: an extreme case of a MSH2 variant and a meta-Analysis. Gene 2014; 546: 421-424
9. Dorschner MO, Amendola LM, Turner EH, et al.; National Heart, Lung and Blood Institute Grand Opportunity Exome Sequencing Project. Actionable, pathogenic incidental findings in 1, 000 participants? exomes. Am J Hum Genet 2013; 93: 631-640
10. Cooper DN, Krawczak M, Polychronakos C, Tyler-Smith C, Kehrer-Sawatzki H. Where genotype is not predictive of phenotype: towards an understanding of the molecular basis of reduced penetrance in human inherited disease. Hum Genet 2013; 132: 1077-1130
11. Richards S, Aziz N, Bale S, et al.; ACMG Laboratory Quality Assurance Committee. Standards and guidelines for the interpretation of sequence variants: a joint consensus recommendation of the American College of Medical Genetics and Genomics and the Association for Molecular Pathology. Genet Med 2015; 17: 405-423
12. Plon SE, Eccles DM, Easton D, et al.; IARC Unclassified Genetic Variants Working Group. Sequence variant classification and reporting: recommendations for improving the interpretation of cancer susceptibility genetic test results. Hum Mutat 2008; 29: 1282-1291
13. Thompson BA, Spurdle AB, Plazzer JP, et al.; InSiGHT. Application of a 5-Tiered scheme for standardized classification of 2, 360 unique mismatch repair gene variants in the InSiGHT locus-specific database. Nat Genet 2014; 46: 107-115
14. Bizon C, Ahalt S, Fecho K, Nassar N, Schmitt C, Scott E and Wilhelmsen K. (2014). Technologies for Genomic Medicine: CANVAS and AnnoBot, Solutions for Genomic Variant Annotation. RENCI, University of North Carolina at Chapel Hill. http://dx.doi.org/10.7921/G0QN64N3. Accessed 17 March 2015
15. Landrum MJ, Lee JM, Riley GR, et al. ClinVar: public archive of relationships among sequence variation and human phenotype. Nucleic Acids Res 2014; 42(database issue): D980-D985
16. Stenson PD, Ball EV, Mort M, et al. Human Gene Mutation Database (HGMD): 2003 update. Hum Mutat 2003; 21: 577-581
17. Exome Aggregation Consortium (ExAC), Cambridge, MA. http://exac. broadinstitute.org. Accessed 17 March 2015
18. Kircher M, Witten DM, Jain P, O'Roak BJ, Cooper GM, Shendure J. A general framework for estimating the relative pathogenicity of human genetic variants. Nat Genet 2014; 46: 310-315
19. Pruitt KD, Brown GR, Hiatt SM, et al. RefSeq: an update on mammalian reference sequences. Nucleic Acids Res 2014; 42(database issue): D756-D763
20. Wilson EB. Probable inference, the law of succession and statistical inference. J Am Stat Assoc 1927; 22: 209-12
21. Risch HA, McLaughlin JR, Cole DE, et al. Population BRCA1 and BRCA2 mutation frequencies and cancer penetrances: a kin-cohort study in Ontario, Canada. J Natl Cancer Inst 2006; 98: 1694-1706
22. Rebbeck TR, Mitra N, Wan F, et al.; CIMBA Consortium. Association of type and location of BRCA1 and BRCA2 mutations with risk of breast and ovarian cancer. JAMA 2015; 313: 1347-1361
23. Feero WG, Wicklund C, Veenstra DL. The economics of genomic medicine: insights from the IOM Roundtable on Translating Genomic-Based Research for Health. JAMA 2013; 309: 1235-1236